Wednesday 8 December 2021

LONGEVITY SCIENCE FOUNDATION WILL USE BLOCKCHAIN TECHNOLOGY IN FUNDING SELECTION

KUALA LUMPUR, Dec 7 (Bernama) -- The Longevity Science Foundation (LSF) — a Swiss non-profit dedicated to advancing the healthy human lifespan — has announced it will use blockchain technology in its funding selection process.

To do so, the Foundation has created LSF Points, which will be distributed to all Foundation donors.

According to a statement, these non-monetary tokens will empower them to vote on which projects and proposals they believe should be funded by the Foundation.

All projects under consideration will first be chosen by the LSF Visionary Board for technical soundness, impact, and scientific quality. 

“Beyond having a credible, strict and transparent evaluation and selection process, the LSF wishes to accommodate a system for donors to also express their opinion and vote for their favourites among the applications,” said Visionary Board Chairman Evelyne Yehudit Bischof.

“This programme will not only encourage donor involvement but will also help us achieve our mission of bringing more longevity-based solutions to a wider audience within the next five years.”

The LSF Points are not an investment instrument and do not have any monetary value. The LSF does not sell nor exchange LSF Points to any currency–they are strictly an instrument for internal decision-making and governance.

However, in addition to votes, donors can use points to earn rewards such as NFTs commemorating contributions, consultations with longevity specialists, and early access to treatments. Point transfers and report security will be managed via a smart contract on an Ethereum-based public blockchain.

“We aim to maintain full transparency while reducing bureaucratic burden in the funding process,” said Bischof. “Every funding decision the Foundation makes is fully auditable applying the new blockchain programme, which guarantees transparency around LSF work.”

The Foundation is seeking to fund projects that can facilitate and accelerate significant progress in longevity medicine as soon as possible. The Foundation’s Visionary Board comprises leading longevity researchers like Bischof, Andrea B. Maier, Eric Verdin, Matt Kaeberlein, Michael Levitt, and Alex Zhavoronkov.

To learn more, visit www.longevity.foundation.

-- BERNAMA

No comments:

Post a Comment